# IMFINZI

NDC: 0310-4611
Generic name: Durvalumab
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170501

FDA application: BLA761069

## Active ingredients

- DURVALUMAB: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-4611"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-4611
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8baba4ea-2855-42fa-9bd9-5a7548d4cec3